June 3, 2019What's New
It is a great honor for Target Health, that Dr. Jules T. Mitchel will be presenting on the topic of Study Designs for Rare Diseases and Regulatory Considerations, at the American Conference on Advanced Treatments in Rare Diseases (RARE2019-USA), taking place on June 13-14, 2019 in East Brunswick, New Jersey, USA. Past and current experiences on novel study designs and FDA interactions will be shared.
RARE2019-USA will address the challenges of Rare Diseases, their diagnosis and treatment as well as on new therapeutic modalities already in advanced stages of development. The Conference will expand on so-called generic topics, such as clinical trials' design, funding for research, digital health, big data on the one hand and focusing on the individual patients for innovation in both drug development and management.
DIA San Diego, 2019
We will be at DIA again this year. Please join us at Booth 2305 and our session on Wednesday June 26 at 10:30 where we will be presenting the profound experience of A Pharma/CRO Partnership in the Design and Execution of Paperless Clinical Trials from eICF to Database Lock. We will be presenting with our colleagues from big pharma, that the paperless trial can and does work. We will also demonstraye, with data, that paperless trials are infinitely more efficient and quality driven than collecting data on pieces of paper and then transcribing these data to EDC systems and then doing so-called SDV.
For more information about Target Health, contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Also visit the Target Health Eating Website to see all of the fantastic recipes since 2012.
Joyce Hays, Founder and Editor in Chief of On Target
Dr. Jules T. Mitchel, Editor